The Group's Turnover from continuing operations amounted to € 341.6 million, posting an increase of 34.6%, compared to the corresponding period of 2020, while Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) from continuing operations amounted to € 96.7 million, increased by 84.5% compared to the nine-month period of the previous year.
Also, Earnings before Taxes (EBT) from continuing operations amounted to € 81 million, higher by 110.8% compared to the corresponding period of 2020.
It should be noted that according to Management estimates, for the nine-month period of 2021, Earnings before Taxes, at α Group level, generated by products of the existing portfolio used in personal protection and health applications, amounted to € 50.7 million.
Regarding the liquidity level, the Group achieved the further enhancement of its liquidity, recording a Net Cash of € 22.7 million, as cash and cash equivalents exceeded its debt liabilities. The total Equity on 30.09.2021 amounted to € 247.9 million, compared to € 174.6 million on 31.12.2020.
From a financial point of view, the Group achieved to increase its revenues and profitability, thus successfully offsetting any negative impact or volatility on demand.
